The first rung of the ladder is built to give way. Here's how to keep climbing.
Short answer: if you're using the Medicare GLP-1 Bridge and your first claim gets rejected at the pharmacy, that may not be a solid no. CMS says that when a patient is eligible and the drug is covered, the program "will still deny the claim but will instruct the pharmacy that a prior authorization is necessary." The denial is how the approval starts.
So the first thing that happens to a qualified patient is a rejection. Pharmacists have been writing about it since July, and last week Pharmacy Times, covering Walgreens' new GLP-1 services, said it again: pharmacy staff "should explain that step so patients do not assume their medication is not covered."
Which raises a fair question about a system: if the rejection needs a script, what is the rejection for?
Why it happens
The Bridge runs outside Part D, through one central processor. A doctor can't get ahead of this by filing the paperwork early. CMS says a prior authorization sent before a pharmacy claim exists fails with the error "patient not found." The claim has to go first, and the claim gets denied.
That's the only reason CMS gives. It's a routing step. It just happens to be routed through the word "denied."
What it looks like at the counter
One pharmacist, writing in July, said the conditioning that "denied means not covered" "is causing patients to read that first rejection as a final answer and leave without their medication." That's one counter, with no count behind it. We found no CMS figure for how many people walk away.
We do know people take a no for an answer elsewhere. In Medicare Advantage in 2024, insurers denied 4.1 million prior authorization requests. Only 11.5% of those denials were appealed, and 80.7% of the appeals were at least partly overturned, per KFF. That covers all services, not just drugs, and the Bridge isn't Medicare Advantage. But it's the same reflex.
In the AMA's latest physician survey, 79% of 1,000 physicians said patients abandon treatment over prior authorization. That's a share of doctors reporting it, not a share of patients.
If your claim gets rejected
- Ask what the rejection says. "Pre-authorization Required" (code 75) is the expected one. Codes 65 and 70 are different: they mean the person or the product isn't eligible.
- Don't leave thinking it's over. The pharmacy sends the form to your prescriber, typically within 24 to 72 hours.
- Call your prescriber if nothing moves. After 72 hours without a request, CMS tells prescribers to download the fax form themselves.
- Watch your mail. The decision comes within 72 hours of submission and is mailed to you.
- If it's denied, know the rules. There's no appeals process in the Bridge. Your prescriber can resubmit with corrected or added information.
What you'd be climbing toward
The copay is $50 a month, and the program runs through December 31, 2027. It covers Wegovy injection and tablets, Foundayo, and the Zepbound KwikPen only. People with type 2 diabetes, among others, stay on their regular Part D route. After the first fill is approved, later fills don't need a new authorization unless you switch drugs. So there's one rung, once.
Where Temi fits
Temi doesn't bill insurance, and our fees are cash-pay. When your coverage at the pharmacy needs a prior authorization, our Care Team does that paperwork on a best-effort basis, at no fee and with no promise of approval, and the prescribing clinician signs it. A prescription isn't guaranteed either: a clinician decides. See if you qualify.
